TY - JOUR
T1 - Brain region-specific gene signatures revealed by distinct astrocyte subpopulations unveil links to glioma and neurodegenerative diseases
AU - Duran, Raquel Cuevas Diaz
AU - Wang, Chih Yen
AU - Zheng, Hui
AU - Deneen, Benjamin
AU - Wu, Jia Qian
N1 - Funding Information:
This work was supported by grants from the National Institutes of Health R01 NS088353; The Staman Ogilvie Fund-Memorial Hermann Foundation; and Mission Connect, a program of the TIRR Foundation, to J.Q.W. and R.C.-D.D.; and National Institutes of Health Grants 1RF1AG054111 and R01NS071153, and National MS Society RG-1501-02756 to B.D. We thank Shun-Fen Tzeng for supporting Chih-Yen and Mary Ann Cushman for editing the paper.
Publisher Copyright:
© 2019 Cuevas-Diaz Duran et al.
PY - 2019/3/1
Y1 - 2019/3/1
N2 - Currently, there are no effective treatments for glioma or for neurodegenerative diseases because of, in part, our limited understanding of the pathophysiology and cellular heterogeneity of these diseases. Mounting evidence suggests that astrocytes play an active role in the pathogenesis of these diseases by contributing to a diverse range of pathophysiological states. In a previous study, five molecularly distinct astrocyte subpopulations from three different brain regions were identified. To further delineate the underlying diversity of these populations, we obtained mouse brain region-specific gene signatures for both protein-coding and long non-coding RNA and found that these astrocyte subpopulations are endowed with unique molecular signatures across diverse brain regions. Additional gene set and single-sample enrichment analyses revealed that gene signatures of different subpopulations are differentially correlated with glioma tumors that harbor distinct genomic alterations. To the best of our knowledge, this is the first study that links transcriptional profiles of astrocyte subpopulations with glioma genomic mutations. Furthermore, our results demonstrated that subpopulations of astrocytes in select brain regions are associated with specific neurodegenerative diseases. Overall, the present study provides a new perspective for understanding the pathophysiology of glioma and neurodegenerative diseases and highlights the potential contributions of diverse astrocyte populations to normal, malignant, and degenerative brain functions.
AB - Currently, there are no effective treatments for glioma or for neurodegenerative diseases because of, in part, our limited understanding of the pathophysiology and cellular heterogeneity of these diseases. Mounting evidence suggests that astrocytes play an active role in the pathogenesis of these diseases by contributing to a diverse range of pathophysiological states. In a previous study, five molecularly distinct astrocyte subpopulations from three different brain regions were identified. To further delineate the underlying diversity of these populations, we obtained mouse brain region-specific gene signatures for both protein-coding and long non-coding RNA and found that these astrocyte subpopulations are endowed with unique molecular signatures across diverse brain regions. Additional gene set and single-sample enrichment analyses revealed that gene signatures of different subpopulations are differentially correlated with glioma tumors that harbor distinct genomic alterations. To the best of our knowledge, this is the first study that links transcriptional profiles of astrocyte subpopulations with glioma genomic mutations. Furthermore, our results demonstrated that subpopulations of astrocytes in select brain regions are associated with specific neurodegenerative diseases. Overall, the present study provides a new perspective for understanding the pathophysiology of glioma and neurodegenerative diseases and highlights the potential contributions of diverse astrocyte populations to normal, malignant, and degenerative brain functions.
UR - http://www.scopus.com/inward/record.url?scp=85064520711&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064520711&partnerID=8YFLogxK
U2 - 10.1523/ENEURO.0288-18.2019
DO - 10.1523/ENEURO.0288-18.2019
M3 - Article
C2 - 30957015
AN - SCOPUS:85064520711
SN - 2373-2822
VL - 6
JO - eNeuro
JF - eNeuro
IS - 2
M1 - e0288-18.2019
ER -